Acorda Therapeutics Stock Operating Margin
| ACOR Stock | USD 0.66 0.12 15.38% |
Acorda Therapeutics fundamentals help investors to digest information that contributes to Acorda Therapeutics' financial success or failures. It also enables traders to predict the movement of Acorda Stock. The fundamental analysis module provides a way to measure Acorda Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Acorda Therapeutics stock.
| Last Reported | Projected for Next Year | ||
| Operating Profit Margin | (0.20) | (0.21) |
Acorda | Operating Margin |
Acorda Therapeutics Company Operating Margin Analysis
Acorda Therapeutics' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Acorda Therapeutics Operating Margin | 0.04 % |
Most of Acorda Therapeutics' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Acorda Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Acorda Operating Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for Acorda Therapeutics is extremely important. It helps to project a fair market value of Acorda Stock properly, considering its historical fundamentals such as Operating Margin. Since Acorda Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Acorda Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Acorda Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionAcorda Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, Acorda Therapeutics has an Operating Margin of 0.039%. This is 100.11% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The operating margin for all United States stocks is 100.71% lower than that of the firm.
Acorda Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Acorda Therapeutics' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Acorda Therapeutics could also be used in its relative valuation, which is a method of valuing Acorda Therapeutics by comparing valuation metrics of similar companies.Acorda Therapeutics is currently under evaluation in operating margin category among related companies.
Acorda Fundamentals
| Return On Equity | -0.24 | ||||
| Return On Asset | -0.0577 | ||||
| Profit Margin | (2.15) % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 161.45 M | ||||
| Shares Outstanding | 1.24 M | ||||
| Shares Owned By Insiders | 0.69 % | ||||
| Shares Owned By Institutions | 13.22 % | ||||
| Number Of Shares Shorted | 8.1 K | ||||
| Price To Earning | 0.95 X | ||||
| Price To Book | 0.05 X | ||||
| Price To Sales | 0.01 X | ||||
| Revenue | 117.63 M | ||||
| Gross Profit | 82.43 M | ||||
| EBITDA | 8.4 M | ||||
| Net Income | (252.85 M) | ||||
| Cash And Equivalents | 20.7 M | ||||
| Cash Per Share | 0.85 X | ||||
| Total Debt | 190.9 M | ||||
| Debt To Equity | 2.56 % | ||||
| Current Ratio | 1.71 X | ||||
| Book Value Per Share | (127.17) X | ||||
| Cash Flow From Operations | (13.98 M) | ||||
| Short Ratio | 1.84 X | ||||
| Earnings Per Share | (203.57) X | ||||
| Price To Earnings To Growth | 0.51 X | ||||
| Target Price | 10.0 | ||||
| Number Of Employees | 102 | ||||
| Beta | 1.46 | ||||
| Market Capitalization | 821.03 K | ||||
| Total Asset | 117.75 M | ||||
| Retained Earnings | (1.19 B) | ||||
| Working Capital | (152.98 M) | ||||
| Current Asset | 451.32 M | ||||
| Current Liabilities | 90.59 M | ||||
| Net Asset | 117.75 M |
About Acorda Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Acorda Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Acorda Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Acorda Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Acorda Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acorda Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acorda Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Acorda Stock
| 0.82 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
Moving against Acorda Stock
| 0.85 | ELYM | Eliem Therapeutics | PairCorr |
| 0.58 | PAHC | Phibro Animal Health Financial Report 1st of May 2024 | PairCorr |
| 0.53 | ANIP | ANI Pharmaceuticals Financial Report 13th of May 2024 | PairCorr |
| 0.49 | OPT | Opthea | PairCorr |
| 0.47 | CNTA | Centessa Pharmaceuticals Downward Rally | PairCorr |
The ability to find closely correlated positions to Acorda Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acorda Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acorda Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acorda Therapeutics to buy it.
The correlation of Acorda Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acorda Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acorda Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acorda Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Acorda Stock analysis
When running Acorda Therapeutics' price analysis, check to measure Acorda Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acorda Therapeutics is operating at the current time. Most of Acorda Therapeutics' value examination focuses on studying past and present price action to predict the probability of Acorda Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acorda Therapeutics' price. Additionally, you may evaluate how the addition of Acorda Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is Acorda Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acorda Therapeutics. If investors know Acorda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acorda Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.873 | Earnings Share (203.57) | Revenue Per Share 94.713 | Quarterly Revenue Growth 0.207 | Return On Assets (0.06) |
The market value of Acorda Therapeutics is measured differently than its book value, which is the value of Acorda that is recorded on the company's balance sheet. Investors also form their own opinion of Acorda Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Acorda Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acorda Therapeutics' market value can be influenced by many factors that don't directly affect Acorda Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acorda Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Acorda Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acorda Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.